300 related articles for article (PubMed ID: 31109089)
1. Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines.
Tataranni T; Agriesti F; Pacelli C; Ruggieri V; Laurenzana I; Mazzoccoli C; Sala GD; Panebianco C; Pazienza V; Capitanio N; Piccoli C
Cells; 2019 May; 8(5):. PubMed ID: 31109089
[TBL] [Abstract][Full Text] [Related]
2. Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment.
Ruggieri V; Agriesti F; Scrima R; Laurenzana I; Perrone D; Tataranni T; Mazzoccoli C; Lo Muzio L; Capitanio N; Piccoli C
Oncotarget; 2015 Jan; 6(2):1217-30. PubMed ID: 25544754
[TBL] [Abstract][Full Text] [Related]
3. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
5. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC.
Stockwin LH; Yu SX; Borgel S; Hancock C; Wolfe TL; Phillips LR; Hollingshead MG; Newton DL
Int J Cancer; 2010 Dec; 127(11):2510-9. PubMed ID: 20533281
[TBL] [Abstract][Full Text] [Related]
6. High-dose vitamin B1 reduces proliferation in cancer cell lines analogous to dichloroacetate.
Hanberry BS; Berger R; Zastre JA
Cancer Chemother Pharmacol; 2014 Mar; 73(3):585-94. PubMed ID: 24452394
[TBL] [Abstract][Full Text] [Related]
7. The effect of dichloroacetate in canine prostate adenocarcinomas and transitional cell carcinomas in vitro.
Harting T; Stubbendorff M; Willenbrock S; Wagner S; Schadzek P; Ngezahayo A; Murua Escobar HM; Nolte I
Int J Oncol; 2016 Dec; 49(6):2341-2350. PubMed ID: 27748833
[TBL] [Abstract][Full Text] [Related]
8. Targeting of two aspects of metabolism in breast cancer treatment.
Gang BP; Dilda PJ; Hogg PJ; Blackburn AC
Cancer Biol Ther; 2014; 15(11):1533-41. PubMed ID: 25482950
[TBL] [Abstract][Full Text] [Related]
9. Influence of dichloroacetate (DCA) on lactate production and oxygen consumption in neuroblastoma cells: is DCA a suitable drug for neuroblastoma therapy?
Niewisch MR; Kuçi Z; Wolburg H; Sautter M; Krampen L; Deubzer B; Handgretinger R; Bruchelt G
Cell Physiol Biochem; 2012; 29(3-4):373-80. PubMed ID: 22508045
[TBL] [Abstract][Full Text] [Related]
10. Dual-targeting of aberrant glucose metabolism in glioblastoma.
Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL
J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202
[TBL] [Abstract][Full Text] [Related]
11. Synergistic anticancer potential of dichloroacetate and estradiol analogue exerting their effect via ROS-JNK-Bcl-2-mediated signalling pathways.
Stander XX; Stander BA; Joubert AM
Cell Physiol Biochem; 2015; 35(4):1499-526. PubMed ID: 25791820
[TBL] [Abstract][Full Text] [Related]
12. Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells.
Sun L; Jiang Y; Yan X; Dai X; Huang C; Chen L; Li T; Zhang Y; Xiao H; Yang M; Xiang L; Zhang Y; Chen S; Li S; Chen A; He F; Lian J
Exp Cell Res; 2021 Sep; 406(1):112755. PubMed ID: 34332981
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants.
Kluza J; Corazao-Rozas P; Touil Y; Jendoubi M; Maire C; Guerreschi P; Jonneaux A; Ballot C; Balayssac S; Valable S; Corroyer-Dulmont A; Bernaudin M; Malet-Martino M; de Lassalle EM; Maboudou P; Formstecher P; Polakowska R; Mortier L; Marchetti P
Cancer Res; 2012 Oct; 72(19):5035-47. PubMed ID: 22865452
[TBL] [Abstract][Full Text] [Related]
14. Dichloroacetate stimulates changes in the mitochondrial network morphology via partial mitophagy in human SH-SY5Y neuroblastoma cells.
Pajuelo-Reguera D; Alán L; Olejár T; Ježek P
Int J Oncol; 2015; 46(6):2409-18. PubMed ID: 25846762
[TBL] [Abstract][Full Text] [Related]
15. Dichloroacetate enhances adriamycin-induced hepatoma cell toxicity in vitro and in vivo by increasing reactive oxygen species levels.
Dai Y; Xiong X; Huang G; Liu J; Sheng S; Wang H; Qin W
PLoS One; 2014; 9(4):e92962. PubMed ID: 24728083
[TBL] [Abstract][Full Text] [Related]
16. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer.
Liu X; Li J; Huang Q; Jin M; Huang G
Mol Med; 2024 Apr; 30(1):56. PubMed ID: 38671369
[TBL] [Abstract][Full Text] [Related]
18. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate.
Schoonjans CA; Joudiou N; Brusa D; Corbet C; Feron O; Gallez B
Cancer Lett; 2020 Feb; 470():18-28. PubMed ID: 31812695
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia enhances antitumor activity of dichloroacetate.
Kolesnik DL; Pyaskovskaya ON; Boichuk IV; Solyanik GI
Exp Oncol; 2014 Dec; 36(4):231-5. PubMed ID: 25537215
[TBL] [Abstract][Full Text] [Related]
20. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism.
Du J; Wang X; Li Y; Ren X; Zhou Y; Hu W; Zhou C; Jing Q; Yang C; Wang L; Li H; Fang L; Zhou Y; Tong X; Wang Y
Cell Death Dis; 2021 Jul; 12(7):705. PubMed ID: 34262021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
